BRAF and melanoma: In the current study we analyzed frequency and type of oncogenic mutations in known oncogenes (BRAF, NRAS, and KIT) involved in melanoma development in large contemporary series of MUP patients with long follow-up, and we correlated these outputs with disease clinical features and outcome.